Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Roche Holding Ltd. (ADR) (NASDAQOTCBB:RHHBY)

CAPS Rating: 5 out of 5

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

How do you think NASDAQOTCBB:RHHBY will perform against the market?

Add Stock to CAPS Watchlist

All Players

221 Outperform
11 Underperform
 

All-Star Players

26 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTCBB:RHHBY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mchedester (76.88)
Submitted March 11, 2013

I don't know why this biotech is so grossly undervalued. I think it is because it is not an American company. But the p/e is well below industry average and the good news about pipeline and approvals just keep pouring in.

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

Recent Community Commentary

Read the most recent pitches from players about RHHBY.

Recs

0
Member Avatar BOHICA101 (< 20) Submitted: 10/14/2021 9:23:22 AM : Outperform Start Price: $48.20 NASDAQ OTC:RHHBY Score: -29.19

I bought this stock 2 weeks ago @$45.60 mainly for the reasons below and I believe it will will out perform the S & P in the coming months,

The U.S. Food and Drug Administration has granted breakthrough therapy designation to Roche Holding AG's gantenerumab for the treatment of people living with Alzheimer's disease.

Roche: Phase 2/3 Trial of Covid-19 Treatment Ronapreve met its primary endpoint.

Results from the trial show that Ronapreve, which is a combination of two antibodies, casirivimab and imdevimab, "significantly" reduces the viral load within seven days in patients who have been hospitalized with Covid-19, the pharmaceutical company said.

Recs

0
Member Avatar Qmac (< 20) Submitted: 3/8/2021 1:39:33 PM : Outperform Start Price: $37.98 NASDAQ OTC:RHHBY Score: -27.31

Leader in DNA diagnostic testing.

Recs

0
Member Avatar bobandkaye (57.24) Submitted: 7/12/2020 2:01:50 PM : Outperform Start Price: $44.21 NASDAQ OTC:RHHBY Score: -60.95

Diagnostics demand for health care

Leaderboard

Find the members with the highest scoring picks in RHHBY.

Score Leader

climate

climate (73.32) Score: +359.42

The Score Leader is the player with the highest score across all their picks in RHHBY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
climate 73.32 3/9/2009 Underperform 1Y $11.30 +217.36% +576.77% +359.42 1 Comment
mikep757 < 20 12/22/2008 Underperform 3Y $14.75 +142.97% +422.45% +279.48 0 Comment
CvsIndnsFan2830 69.09 3/18/2008 Underperform 1Y $18.33 +95.54% +265.67% +170.13 0 Comment
Master1958jade < 20 7/4/2008 Underperform NS $17.78 +101.66% +262.50% +160.84 0 Comment
Lonewolf7107 < 20 11/12/2012 Underperform 5Y $20.21 +77.36% +228.51% +151.15 0 Comment
MrOneHundred 29.96 11/19/2012 Underperform NS $19.91 +80.06% +229.78% +149.71 0 Comment
RafaelCanadaRed 82.07 5/7/2013 Underperform 5Y $27.39 +30.87% +180.49% +149.62 0 Comment
wsb1999 63.42 4/10/2008 Underperform NS $18.34 +95.45% +244.69% +149.24 0 Comment
zkoerber 97.03 10/7/2010 Underperform 1Y $14.20 +152.43% +293.22% +140.79 0 Comment
GrandeTeam 25.59 11/16/2011 Underperform 5Y $16.13 +122.22% +260.72% +138.50 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RHHBY.